<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Focused International Growth Fund R Class — News on 6ix</title>
    <link>https://6ix.com/company/focused-international-growth-fund-r-class</link>
    <description>Latest news and press releases for Focused International Growth Fund R Class on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 22 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/focused-international-growth-fund-r-class" rel="self" type="application/rss+xml" />
    <item>
      <title>Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</title>
      <link>https://6ix.com/company/focused-international-growth-fund-r-class/news/lifecore-announces-inducement-grant-under-nasdaq-listing-rule-5635c4-5</link>
      <guid isPermaLink="true">https://6ix.com/company/focused-international-growth-fund-r-class/news/lifecore-announces-inducement-grant-under-nasdaq-listing-rule-5635c4-5</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>CHASKA, Minn., April 22, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated injectables contract development</description>
    </item>
    <item>
      <title>ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint</title>
      <link>https://6ix.com/company/focused-international-growth-fund-r-class/news/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alphar-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint-73</link>
      <guid isPermaLink="true">https://6ix.com/company/focused-international-growth-fund-r-class/news/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alphar-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint-73</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (&quot;Company&quot;), a global device, cell, and gene therapy-enabling</description>
    </item>
    <item>
      <title>Amentum Appoints Joseph DeNardi as Senior Vice President and Head of Investor Relations</title>
      <link>https://6ix.com/company/focused-international-growth-fund-r-class/news/amentum-appoints-joseph-denardi-as-senior-vice-president-and-head-of-investor-relations-36</link>
      <guid isPermaLink="true">https://6ix.com/company/focused-international-growth-fund-r-class/news/amentum-appoints-joseph-denardi-as-senior-vice-president-and-head-of-investor-relations-36</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>CHANTILLY, Va.--(BUSINESS WIRE)-- Amentum (NYSE: AMTM), a global leader in advanced engineering and technology solutions, today announced the appointment of</description>
    </item>
  </channel>
</rss>